- Matthew Todd
- School of Chemistry, Building F11, The University of Sydney, NSW 2006, Sydney, Australia
I manage the Todd Lab at the University of Sydney.
If you're looking for our open science stuff, try some of these links:
The Synaptic Leap
our PZQ LabBlog for some raw data
or more raw data in our open source drug discovery for malaria project, as well as the associated wiki
some of our papers
or some papers we're writing
or maybe an overview of what we think open science is, courtesy of a free [www.nature.com/uidfinder/10.1038/nchem.1149 Nature Chemistry article].
- 2005-, Lecturer then Senior Lecturer, University of Sydney
- 2001-2005, Lecturer in Chemistry, Queen Mary, University of London
- 2000-2001, College Fellow and Lecturer, New Hall College, Cambridge University
- 1999-2000, Postdoc, University of California, Berkeley
- 1999, PhD, Organic Chemistry, Cambridge University
- 1995, MA, Natural Science, Cambridge University
- Organic synthesis and methodology
- Asymmetric Catalysis
- Chemical Biology
- Open Science
See the main lab list
Mat Todd was born in Manchester, England. He obtained his PhD in organic chemistry from Cambridge University in 1999, was a Wellcome Trust postdoc at The University of California, Berkeley, a college fellow back at Cambridge University, a lecturer at Queen Mary, University of London and since 2005 has been at the School of Chemistry, The University of Sydney where he is currently Senior Lecturer.
His research interests include the development of new ways to make molecules, particularly how to make chiral molecules with new catalysts. He is also interested in making metal complexes that do unusual things when they meet biological molecules. His lab motto is "To make the right molecule in the right place at the right time", though the group do not currently know what this means.
He has a growing interest in Open Science, and how it may be used to accelerate research, with particularly emphasis on open source drug discovery. He is Chair of The Synaptic Leap, a nonprofit dedicated to open biomedical research and is on the Editorial Boards of PLoS One, Chemistry Central Journal and ChemistryOpen.